-
公开(公告)号:DE4427648A1
公开(公告)日:1996-02-08
申请号:DE4427648
申请日:1994-08-04
Applicant: BASF AG
Inventor: STEINER GERD DR , MUNSCHAUER RAINER DR , HOEGER THOMAS DR , UNGER LILIANE DR , TESCHENDORF HANS-JUERGEN DR ME
IPC: C07D401/06 , A61K31/40 , A61K31/415 , A61K31/47 , A61K31/505 , A61P25/18 , A61P43/00 , C07D403/06 , C07D471/04 , C07D513/04 , C07D513/02
Abstract: Compounds are disclosed having the formula (I), in which R , R , A, X, Y and Z have the meanings given in the description, as well as their preparation. These new compounds are useful for fighting diseases.
-
公开(公告)号:DE4325435A1
公开(公告)日:1995-02-02
申请号:DE4325435
申请日:1993-07-29
Applicant: BASF AG
Inventor: SCHLECKER RAINER DR , TESCHENDORF HANS-JUERGEN DR ME
IPC: A61K31/37 , A61K31/195
-
公开(公告)号:DE4119758A1
公开(公告)日:1992-12-17
申请号:DE4119758
申请日:1991-06-15
Applicant: BASF AG
IPC: A61K31/41 , A61K31/433 , A61K31/435 , A61K31/4439 , A61K31/454 , A61K31/495 , A61K31/496 , A61P9/12 , A61P25/00 , A61P25/16 , A61P25/18 , A61P43/00 , C07D285/12 , C07D285/125 , C07D285/135 , C07D417/12
Abstract: Described are aminoalkyl-substituted 2-amino-5-mercapto-1,3,4-thiadiazole derivatives of formula (I), in which A and n are as defined in the description, as well as their preparation. The compounds are suitable for use in the treatment of illnesses.
-
公开(公告)号:DE4119755A1
公开(公告)日:1992-12-17
申请号:DE4119755
申请日:1991-06-15
Applicant: BASF AG
IPC: A61K31/395 , A61K31/433 , A61K31/4439 , A61K31/445 , A61K31/454 , A61K31/495 , A61K31/41 , A61K31/496 , A61K31/506 , A61P9/12 , A61P25/00 , A61P25/16 , A61P25/18 , A61P43/00 , C07D285/12 , C07D285/135 , C07D417/06 , C07D417/12 , C07D417/14
Abstract: Described are aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles of formula (I), in which n and A are as defined in the description, as well as their preparation. The compounds are suitable for use in the treatment of illnesses.
-
公开(公告)号:DE3717069A1
公开(公告)日:1988-12-08
申请号:DE3717069
申请日:1987-05-21
Applicant: BASF AG
IPC: A61K31/55 , A61P21/02 , A61P25/00 , A61P25/20 , C07D495/04
Abstract: Compounds of the formula I where R1, R2, R3 and A have the meanings stated in the specification, as well as the use thereof for controlling diseases, are described.
-
公开(公告)号:DE3037971A1
公开(公告)日:1982-05-13
申请号:DE3037971
申请日:1980-10-08
Applicant: BASF AG
Inventor: STEINER GERD DIPL CHEM DR , TESCHENDORF HANS-JUERGEN DR ME , KREISKOTT HORST DR , HOFMANN HANS PETER DR
IPC: A61K31/55 , A61P25/00 , A61P25/08 , A61P25/20 , C07D223/00 , C07D333/00 , C07D495/14 , C07D495/12 , A61K31/35
-
公开(公告)号:DE19636769A1
公开(公告)日:1998-03-12
申请号:DE19636769
申请日:1996-09-10
Applicant: BASF AG
Inventor: STEINER GERD DR , LUBISCH WILFRIED DR , BACH ALFRED DR , EMLING FRANZ DR , WICKE KARSTEN DR , TESCHENDORF HANS-JUERGEN DR ME , BEHL BERTHOLD DR , KERRIGAN FRANK DR , CHEETHAM SHARON DR
IPC: A61K31/435 , A61K31/519 , A61P25/24 , A61P43/00 , C07D211/00 , C07D239/00 , C07D333/00 , C07D495/14 , A61K31/44 , A61K31/38 , A61K31/505
Abstract: The invention concerns 3-substituted 3,4,5,6,7,8-hexahydro-pyrido[4,3':4,5]thieno-[2,3-d]pyrimidine derivatives of formula (I) in which: R designates a hydrogen atom, a C1-C4 alkyl group, an acetyl or benzoyl group, a phenylalkyl C1-C4 group - the aromatic optionally being substituted by halogen, C1-C4 alkyl, trifluoromethyl, hydroxy, C1-C4 alkoxy, amino, cyano or nitro groups - a naphthylalkyl C1-C3 group, a phenylalkanone C2-C3 group or a phenylcarbamoylalkyl C2 group, wherein the phenyl group can be substituted by halogen; R designates a phenyl, pyridyl, pyrimidinyl or pyrazinyl group which can optionally be mono-, di- or tri-substituted by halogen atoms, C1-C4 alkyl, trifluoromethyl, trifluoromethoxy, hydroxy, C1-C4 alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups and can optionally be anellated with a benzene nucleus, which can optionally be mono- or di-substituted by halogen atoms, C1-C4 alkyl, hydroxy, trifluoromethyl, C1-C4 alkoxy, amino, cyano or nitro groups and can optionally contain 1 nitrogen atom, or with a 5- or 6-member ring which can contain between 1 and 2 oxygen atoms, or can be substituted by a phenyl-C1-C2 alkyl or alkoxy group, wherein the phenyl group can be substituted by halogen, a methyl, trifluoromethyl or methoxy group; A designates NH or an oxygen atom; B designates hydrogen or methyl; C designates hydrogen, methyl or hydroxy; X designates a nitrogen atom; Y is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH; Z designates a nitrogen atom, a carbon atom or CH, wherein the bond between Y and Z can also be a double bond; and n is the number 2, 3 or 4, and their physiologically compatible salts. These compounds are suitable as medicaments for treating diseases in which the serotonin concentration is reduced and in which the activity of the presynaptic receptors 5-HT1B, 5-HT1A, 5HT1D is to be blocked within a therapeutic context without greatly influencing other receptors. Such diseases include, for example, depression.
-
公开(公告)号:DE19532050A1
公开(公告)日:1997-03-06
申请号:DE19532050
申请日:1995-08-31
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , BEHL BERTHOLD DR , HOFMANN HANS PETER DR , TESCHENDORF HANS-JUERGEN DR ME
IPC: A61K31/00 , A61K31/495 , A61K31/498 , A61P25/04 , C07D401/14 , C07D403/04
Abstract: Pyrrolyl tetrahydroquinoxalin diones of formula (I) and their tautomeric and isomeric forms, and their physiologically acceptable salts, in which the variables are: R - hydrogène, cyclohexyl radical, an aliphatic radical with 1 to 4 atoms which can bear the radical COOR , where R is hydrogen or C1-C4 alkyl, R -COOH, -COO-C1-C4, -COO-(CH2)m-Ph, -CONR R and (a), where m may be a whole number from 1 to 6, R is hydrogen, -C1-C4 alkyl or OH and R is hydrogen, -C1-C4 alkyl, -(CH2)m-Ph or (b), where all the phenyl or pyridyl rings contained in R may be substituted by up to 3 of the following radicals: -C1-C4 alkyl, halogen, -O-C1-C4 alkyl, -OCF3, -NO2, -CN, -COOR or -CONHR ; R is -CF3, -NO2, -CN and R is hydrogen; or R and R together may be an anellated benzole ring. The compounds are suitable as medicaments in human and veterinary medicine.
-
公开(公告)号:DE4112353A1
公开(公告)日:1992-10-22
申请号:DE4112353
申请日:1991-04-16
Applicant: BASF AG
Inventor: STEINER GERD DR , UNGER LILIANE DR , HOFMANN HANS PETER DR , TESCHENDORF HANS-JUERGEN DR ME , BEHL BERTHOLD DR , BINDER RUDOLF DR
IPC: A61K31/445 , A61K31/4433 , A61K31/451 , A61P25/20 , A61P25/24 , A61P25/26 , C07D211/22 , C07D211/46 , C07D211/48 , C07D211/52 , C07D211/70 , C07D409/04
Abstract: The description relates to compounds of formula (I) in which A-B-D, R , R , R and n have the meanings given in the specification, and their production. The compounds are suitable for the treatment of diseases.
-
公开(公告)号:DE3717395A1
公开(公告)日:1988-12-08
申请号:DE3717395
申请日:1987-05-23
Applicant: BASF AG
Inventor: STEINER GERD DR , HIMMELE WALTER DR , BUSCHMANN ERNST DR , TESCHENDORF HANS-JUERGEN DR ME , WEIFENBACH HARALD DR
IPC: A61K31/40 , A61K31/403 , A61P25/08 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D209/60
Abstract: A 5-phenyl-1,3,3a,4,5,9b-hexahydro-3H-benz(e)indole compound of the formula I: I wherein R1 is hydrogen or C1-6 alkyl, R2 is hydrogen or C1-3 alkyl in the 3a- or 4-position, R3 and R4 are each hydrogen, hydroxyl, halogen, C1-3 alkyl, C1-3 alkoxy, C1-3 alkylthio or trifluoromethyl, acetylamino or amino and R5 is hydrogen or C1-3 alkyl, or a salt thereof with a physiologically tolerated acid. The compounds and compositions are useful for treating depression or trating convulsions and which exhibit a sedative and tranquilizing effect when administered to a patient.
-
-
-
-
-
-
-
-
-